Jerónimo Martins (JMT) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
30 Jun, 2026Executive summary
Sales reached €26.5 billion, up 7.1% year-over-year, with strong like-for-like growth and robust expansion, especially in Poland and Colombia.
EBITDA rose 10.9% to €1.8 billion, with margin improvement to 6.8% (+23 bps), driven by sales growth, cost discipline, and efficiency despite rising wage costs.
Net profit attributable to shareholders increased 10% to €484 million, with EPS up 10% to €0.77.
274 new stores were opened and 170 locations remodeled in the first nine months, supporting network expansion.
Capex execution reached €816 million, supporting network expansion and store renovations.
Financial highlights
Net sales and services grew 7.1% year-over-year to €26,534 million.
EBITDA increased 10.9% to €1,811 million; EBIT up 12.8% to €964 million.
Net profit attributable to shareholders was €484 million, up 10% year-over-year.
Net cash position (excluding capitalized leases/IFRS16) stood at €467 million at September end; net debt at €3.6 billion.
Cash flow before dividends was €128 million; capex reached €816 million.
Outlook and guidance
2025 expected to remain volatile due to geopolitical and economic instability; focus on price competitiveness, operational efficiency, and agile response to consumer needs.
Capex for 2025 projected slightly above €1 billion, with continued focus on store expansion and renovations across all banners.
Biedronka plans 130–150 net new stores and c.200 renovations; Ara expects over 150 new stores and further logistics investment.
Hebe to open c.30 new stores in Poland, maintaining e-commerce as a growth pillar.
Pingo Doce to remodel c.50 stores and open c.10 new locations in Portugal.
Latest events from Jerónimo Martins
- Sales and EBITDA rose, but net profit declined due to higher costs and geopolitical risks.JMT
Q1 202612 May 2026 - Sales and EBITDA grew strongly, with robust expansion and disciplined execution across all markets.JMT
Q4 202519 Mar 2026 - Sales up 12.3% to €16.3bn, but net profit down 29% amid margin and cost pressures.JMT
H1 20243 Feb 2026 - Sales up 10.3% to €24.8B, but net profit and margins fell amid cost and deflation pressures.JMT
Q3 202417 Jan 2026 - Sales rose 7.6% to €35,991 million, driven by expansion and strong LFL growth across all banners.JMT
Q4 2025 TU13 Jan 2026 - Sales up 9.3% to €33.5bn, net profit down 20.8%, major 2025 investments planned.JMT
H2 202414 Dec 2025 - Sales and profit rose 3.8%, but margin pressure and volatility persist.JMT
Q1 202518 Nov 2025 - 6.7% sales growth, 10.3% EBITDA rise, and 6.6% profit gain, with robust expansion and margin discipline.JMT
Q2 20252 Nov 2025